Columbamine (Alkaloid)

Columbamine is an alkaloid compound that functions as a metabolite of berberine and demonstrates significant interaction with P-glycoprotein drug efflux transporters. This compound exhibits an efflux ratio of 5.68 in vitro studies, indicating its potential role in modulating cellular drug transport mechanisms.

Origin & History

Columbamine is a protoberberine alkaloid with molecular formula C20H20NO4+ naturally found in plants including Fibraurea chloroleuca, Corydalis ternata, calumba root, and Rhizoma Coptidis. It is isolated as a quaternary isoquinoline alkaloid from these herbal sources, though specific extraction methods are not detailed in available research.

Historical & Cultural Context

Columbamine was first identified in calumba root and has been extracted from traditional Chinese herbs like Rhizoma Coptidis. However, specific historical therapeutic uses or traditional medicine applications are not detailed in available sources.

Health Benefits

• P-glycoprotein interaction: In vitro studies show columbamine interacts with P-gp drug efflux transporter with an efflux ratio of 5.68, lower than berberine (preliminary evidence)
• Metabolite of berberine: Functions as a metabolite of berberine and may share some biological activities (preliminary evidence)
• Enzyme targeting: Reported to target various enzyme classes including oxidoreductases, transferases, and matrix metalloproteinases (preliminary evidence)
• Potential drug interaction modulation: P-gp substrate activity suggests possible influence on drug absorption and distribution (preliminary evidence)
• Diverse biological activities: Sources mention various biological activities though specific effects not detailed (preliminary evidence)

How It Works

Columbamine primarily functions through interaction with P-glycoprotein (P-gp) efflux transporters, showing an efflux ratio of 5.68 in laboratory studies. As a metabolite of berberine, it likely modulates similar cellular pathways including ATP-binding cassette transporter systems. The compound may influence drug bioavailability and cellular uptake through its P-gp modulation effects.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on columbamine have been conducted. Research is limited to in vitro studies, including cell model experiments showing P-gp interaction with apparent permeability of 0.34 × 10⁻⁶ cm/s (AP-BL) and 1.94 × 10⁻⁶ cm/s (BL-AP) at 10 μM concentration.

Clinical Summary

Current evidence for columbamine is limited to preliminary in vitro studies examining its interaction with P-glycoprotein transporters. Laboratory research demonstrates measurable efflux activity with a ratio of 5.68, though this is lower than its parent compound berberine. No human clinical trials or animal studies have been published specifically investigating columbamine's therapeutic effects. Evidence remains at the preliminary cellular level with no established clinical applications.

Nutritional Profile

Columbamine is a protoberberine-type isoquinoline alkaloid (molecular formula: C₂₀H₂₁NO₄; molecular weight: ~339.39 g/mol) and is not a nutritional source of macronutrients, vitamins, or minerals. It is a bioactive secondary metabolite found in trace to minor concentrations in plants of the families Berberidaceae, Ranunculaceae, and Menispermaceae — notably in Coscinium fenestratum, Tinospora cordifolia, Coptis chinensis, and various Berberis species. Typical concentrations in source plants range from approximately 0.01–0.5% dry weight depending on species, plant part, and extraction method. Structurally, columbamine is a 2,3-methylenedioxy-9,10-dimethoxyprotoberberine alkaloid featuring a quaternary nitrogen and a phenolic hydroxyl group, distinguishing it from the closely related berberine (which bears a methylenedioxy group at positions 2,3 and 9,10). Columbamine also occurs as a Phase I demethylated metabolite of berberine via hepatic CYP450-mediated metabolism in vivo. Bioavailability is expected to be low, consistent with other protoberberine alkaloids — oral absorption is limited (estimated <5%) due to poor intestinal permeability, significant P-glycoprotein-mediated efflux (efflux ratio ~5.68 in Caco-2 models), and extensive first-pass hepatic metabolism. It undergoes Phase I (demethylation, hydroxylation) and Phase II (glucuronidation, sulfation) biotransformation. No significant content of dietary fiber, protein, fat, carbohydrates, vitamins, or essential minerals is attributable to columbamine itself. Its relevance is solely as a trace bioactive phytochemical or drug metabolite rather than a nutritional component.

Preparation & Dosage

No clinically studied dosage ranges have been established for columbamine as human trials are absent. No standardized forms (extract, powder) or dosing recommendations are available from research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Berberine, Coptis chinensis extract, P-glycoprotein inhibitors, Fibraurea chloroleuca extract

Safety & Interactions

Safety data for columbamine is extremely limited due to lack of clinical research and human studies. As a berberine metabolite that interacts with P-glycoprotein transporters, it may potentially affect the absorption and elimination of various medications. Drug interactions are theoretically possible but remain unstudied in clinical settings. Pregnancy and lactation safety have not been established due to insufficient research data.